Cough Cancer
121 Followers
Recent papers in Cough Cancer
La respiración es importante porque permite realizar el intercambio gaseoso permitiendo la entrada de oxígeno y la expulsión de dióxido de carbono: esto ocurre en dos fases bien definidas, una de inspiración o entrada del aire y una de... more
La respiración es importante porque permite realizar el intercambio gaseoso permitiendo la entrada de oxígeno y la expulsión de dióxido de carbono: esto ocurre en dos fases bien definidas, una de inspiración o entrada del aire y una de espiración o salida del aire. El oxígeno es importante para ayudar a obtener la energía necesaria para los diferentes procesos celulares. El intercambio gaseoso es de primera importancia para el organismo. En el aparato respiratorio hay dos componentes principales, uno de conducción y uno de intercambio. El enorme volumen de aire que pasa por los pulmones con todas las partículas extrañas que vienen en suspensión, hace necesario un sistema de limpieza que en el pulmón comprende el surfactante, el ascendente mucociliar, los macrófagos alveolares y la tos. El aparato respiratorio tiene abundante inervación autonómica, predominando la de la rama parasimpática, responsable de producir tos por medio de las fibras receptoras aferentes que son de tres tipos, de producir broncoconstricción y disminución de los volúmenes alveolares. El estímulo ventilatorio procede de acúmulos de neuronas en el tallo cerebral, denominados los centros respiratorios, que emiten los impulsos al nervio vago (uno de los nervios del parasimpático que inerva abundamente el pulmón) para que se produzca la contracción del músculo diafragma y consecuentemente, la fase de inspiración.
Dear Sir/Madam We are currently hosting the Oncologist & Diagnostics Conference which is going to be organized during August 28-30, 2017 Brussels, Belgium. With great pride and honour, we would like to invite you to participate in... more
Dear Sir/Madam
We are currently hosting the Oncologist & Diagnostics Conference which is going to be organized during August 28-30, 2017 Brussels, Belgium. With great pride and honour, we would like to invite you to participate in Oncologist & Diagnostics Conference in Brussels, Belgium
Kindly let me know about you interest toward participation as a Keynote, Speaker, Poster presentation, E-Poster and Video Presentation, delegate.
Kindly find the attached file for conference details
Kindly contact us for any sort of further assistance.
We sincerely hope that you will honour us by accepting our invitation
Regards
Celina Crystal
Manager of oncology and conferences
P 702 508 5200 Ext 8033
#cancerdiagnostics@cancersummit.org
************************************************************************
ConferenceSeries Ltd invites all the participants across the globe to attend the Oncologist & Diagnostics Conference slated on August 28-30, 2017 at Brussels, Belgium.
Cancer Diagnostics 2017 directs towards addressing main issues as well as future strategies of Cancer. This is going to be the largest and most promising international conference where the program includes Clinical Oncologists, Registered Nurses, Nurse practitioners and the entire medical team involved in patient care, researchers, professional, early career individuals and patient advocates who wish to learn principles of tumor immunology and immunotherapy well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of Cancers. Cancer Diagnostics 2017 will also provide the three days of discussions on methods and strategies related to management and quality improvement of Diagnostics device developing and Cancer Research and as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer, leukemia, blood cancer, cervical cancer, colon-rectum cancer, pediatric cancer, surgical cancer, Prostate cancer, thyroid cancer.
According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increase in the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Nearly 60% of the world’s total new cases occur in the Africa, Asia and Central and South America regions. All over the world Denmark ranks 1st in the cancer deaths USA is accompanied next to it.
ConferenceSeries Ltd which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. It hosts numerous Cancer Conferences, Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.
Why Brussels???
Brussels, a region of Belgium comprising 19 municipalities, is a city of contrasts with enormous diversity, experiencing cool climates all throughout the year. Brussels is also becoming known as a mecca of style, art, and design having bilingualism of Modern French and Old Dutch.
We are currently hosting the Oncologist & Diagnostics Conference which is going to be organized during August 28-30, 2017 Brussels, Belgium. With great pride and honour, we would like to invite you to participate in Oncologist & Diagnostics Conference in Brussels, Belgium
Kindly let me know about you interest toward participation as a Keynote, Speaker, Poster presentation, E-Poster and Video Presentation, delegate.
Kindly find the attached file for conference details
Kindly contact us for any sort of further assistance.
We sincerely hope that you will honour us by accepting our invitation
Regards
Celina Crystal
Manager of oncology and conferences
P 702 508 5200 Ext 8033
#cancerdiagnostics@cancersummit.org
************************************************************************
ConferenceSeries Ltd invites all the participants across the globe to attend the Oncologist & Diagnostics Conference slated on August 28-30, 2017 at Brussels, Belgium.
Cancer Diagnostics 2017 directs towards addressing main issues as well as future strategies of Cancer. This is going to be the largest and most promising international conference where the program includes Clinical Oncologists, Registered Nurses, Nurse practitioners and the entire medical team involved in patient care, researchers, professional, early career individuals and patient advocates who wish to learn principles of tumor immunology and immunotherapy well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of Cancers. Cancer Diagnostics 2017 will also provide the three days of discussions on methods and strategies related to management and quality improvement of Diagnostics device developing and Cancer Research and as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer, leukemia, blood cancer, cervical cancer, colon-rectum cancer, pediatric cancer, surgical cancer, Prostate cancer, thyroid cancer.
According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increase in the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Nearly 60% of the world’s total new cases occur in the Africa, Asia and Central and South America regions. All over the world Denmark ranks 1st in the cancer deaths USA is accompanied next to it.
ConferenceSeries Ltd which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. It hosts numerous Cancer Conferences, Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.
Why Brussels???
Brussels, a region of Belgium comprising 19 municipalities, is a city of contrasts with enormous diversity, experiencing cool climates all throughout the year. Brussels is also becoming known as a mecca of style, art, and design having bilingualism of Modern French and Old Dutch.
Invitation Conference Series LLC welcomes you to attend the 2nd Cancer Diagnostics Conference & Expo during May 08-10, 2017 Barcelona, Spain. We cordially invite all the participants who are interested in sharing their knowledge and... more
Invitation
Conference Series LLC welcomes you to attend the 2nd Cancer Diagnostics Conference & Expo during May 08-10, 2017 Barcelona, Spain.
We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of 2nd Cancer Diagnostics Conference & Expo.
Cancer Diagnostics 2017 anticipates more than 200 participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates include Editorial Board Members of related Conference Series LLC Journals.
This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.
The intending participants can confirm their participation by registering for the conference along with your colleagues. Avail the delegate early bird offer.
The main theme of the conference is “An insight into Advancing New methods of Cancer Diagnostics”
Regards,
Cancer Diagnostics 2017
Operating Committee
Cancer
Diagnostics 2017
Conference Series LLC welcomes you to attend the 2nd Cancer Diagnostics Conference & Expo during May 08-10, 2017 Barcelona, Spain.
We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of 2nd Cancer Diagnostics Conference & Expo.
Cancer Diagnostics 2017 anticipates more than 200 participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates include Editorial Board Members of related Conference Series LLC Journals.
This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.
The intending participants can confirm their participation by registering for the conference along with your colleagues. Avail the delegate early bird offer.
The main theme of the conference is “An insight into Advancing New methods of Cancer Diagnostics”
Regards,
Cancer Diagnostics 2017
Operating Committee
Cancer
Diagnostics 2017
Introduction: Intractable and persistent cough is experienced by more than a third of patients with advanced cancer, with a significant negative impact on quality of life. Pharmacological treatment has been of little help in some... more
Introduction: Intractable and persistent cough is experienced by more than a third of patients with advanced cancer, with a significant negative impact on quality of life. Pharmacological treatment has been of little help in some patients. Limited evidence suggests novel agents such as paroxetine may reduce cough severity. This retrospective study aimed to assess effectiveness and tolerability of paroxetine for the treatment of intractable cough in patients with cancer. Methods: Single-centre medical record review of paroxetine use in patients with advanced malignancy and cough treated at an Australia tertiary referral cancer centre between 1 October 2012 and 1 October 2017. Data relating to cough type and severity, response and adverse events were extracted from medical records. Cough type was described as non-productive dry cough, productive chesty cough or cough exhibiting both non-productive and productive features (mixed cough). Results: Overall, 24/34 patients (71%) experienced a major or moderate reduction in their cough severity after treatment with paroxetine. Nearly half (47%) described a major improvement and a quarter (24%) moderate improvement. Of the 34 patients, nearly half had a lung primary cancer (16/34, 47%) and nearly all (17/18) of those without lung cancer had lung metastases from another primary cancer. Patients with dry cough reported greater benefit from paroxetine. Of the 56% (19/34) of patients with non-productive dry cough, 80% (15/19) reported an improvement in symptoms post paroxetine. The remaining 15 patients, 44% of the group, presented with either a productive chesty cough (9/34, 27%) or mixed cough (6/34, 18%). Of these patients, 60% (9/15) reported an improvement in symptoms. Two thirds of patients were commenced on paroxetine 10 mg (22/34, 65%), with the remainder starting at 20 mg (14/34, 35%). Conclusion: Paroxetine may be an effective, novel, off-label treatment for intractable and persistent cough in patients with advanced cancer.
- by Sonia Fullerton and +2
- •
- Cancer, Cough Cancer, Cough
Related Topics